ReShape Lifesciences (RSLS) 10-Q2022 Q3 Quarterly report

Filed: 14 Nov 22, 5:23pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accurate, authorize, authorized, bid, block, Bulletin, CA, case, concurrent, confidence, consecutive, cure, delisted, delisting, detailed, efficient, encourage, forfeiture, guarantee, history, hypoglycemia, Innovation, intention, joined, lead, likelihood, longer, lower, Mirroring, nerve, notice, OTC, penny, permanent, pink, Preferred, proportion, proportionately, proposal, proposed, proprietary, publicly, purpose, quotation, regain, registered, rescind, rescission, scheduled, secondary, service, Specifically, stimulation, stockholder, stopping, submission, surgical, thereunder, unchanged, vBloc

Removed: equipment, increasing, led, periodically, presence, record, reducing, resurgence, usage

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated RSLS transcripts

RSLS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Thomas Stankovich, in his capacity as Chief Financial Officer of ReShape Lifesciences Inc., hereby certifies that, to the best of his knowledge:

The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 to which this Certification is attached as Exhibit 32.2 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

The information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of ReShape Lifesciences Inc. as of, and for, the periods covered by the Report.


	By:	/s/ THOMAS STANKOVICH
		Thomas Stankovich
		Chief Financial Officer, Senior Vice President, Finance

Date: November 14, 2022

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.